Yang-Hsiang Lin
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 17
- Cancer, Hypoxia, and Metabolism 9
- MicroRNA in disease regulation 8
- Molecular Biology top 10%
- RNA modifications and cancer 18
- RNA Research and Splicing 8
- Circular RNAs in diseases 7
- Hepatology top 10%
-
- Liver Disease Diagnosis and Treatment 10
- Hepatitis B Virus Studies 9
- Co-authors
- Kwang‐Huei LinChau‐Ting YehHsiang‐Cheng ChiI‐Hsiao ChungChung‐Ying TsaiYa‐Hui HuangMing-Ming TsaiMeng‐Han Wu
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Yang-Hsiang Lin
56 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Cancer Research 683
- Molecular Biology 834
- Hepatology 92
- Oncology 193
- Endocrinology, Diabetes and Metabolism 109
Countries citing papers authored by Yang-Hsiang Lin
This map shows the geographic impact of Yang-Hsiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang-Hsiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang-Hsiang Lin more than expected).
Fields of papers citing papers by Yang-Hsiang Lin
This network shows the impact of papers produced by Yang-Hsiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang-Hsiang Lin. The network helps show where Yang-Hsiang Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yang-Hsiang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 11 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 26 | |
| 11 | 2019 | 22 | |
| 12 | 2019 | 23 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 11 | |
| 15 | 2015 | 47 | |
| 16 | 2014 | 71 | |
| 17 | 2013 | 24 | |
| 18 | 2011 | 37 | |
| 19 | 2011 | 59 | |
| 20 | 2009 | 105 |
About Yang-Hsiang Lin
Yang-Hsiang Lin is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (18 papers), Cancer-related molecular mechanisms research (17 papers), Liver Disease Diagnosis and Treatment (10 papers), Hepatitis B Virus Studies (9 papers), Cancer, Hypoxia, and Metabolism (9 papers), MicroRNA in disease regulation (8 papers), RNA Research and Splicing (8 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Cancer Research (683 citations), Molecular Biology (834 citations) and Hepatology (92 citations). Yang-Hsiang Lin has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Kwang‐Huei Lin, Chau‐Ting Yeh, Hsiang‐Cheng Chi, I‐Hsiao Chung, Chung‐Ying Tsai, Ya‐Hui Huang, Ming-Ming Tsai, Meng‐Han Wu, Yi‐Hsin Tseng and Wei-Jan Chen. Their work appears in journals such as PLoS ONE, Hepatology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.